SCOPUS 정보 검색 플랫폼

Journal of Child Neurology

Volumn 28, Issue 9, 2013, Pages 1112-1116

A novel c.1135-1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis

(3) Drack, Arlene V a Miller, Jake N b Pearce, David A b,c

a UNIVERSITY OF IOWA (United States)

b UNIVERSITY OF SOUTH DAKOTA (United States)

c UNIVERSITY OF SOUTH DAKOTA (United States)

Author keywords

Batten disease; CLN3; juvenile neuronal ceroid lipofuscinosis; neuronal ceroid lipofuscinosis

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN CLN3; UNCLASSIFIED DRUG;

ARTICLE; ASTIGMATISM; ATTENTION DEFICIT DISORDER; CASE REPORT; CHILD; COLOR BLINDNESS; COLOR VISION TEST; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE DELETION; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HEMANGIOMA; HUMAN; HUMAN CELL; INTELLIGENCE; NEURONAL CEROID LIPOFUSCINOSIS; NONSENSE MEDIATED MRNA DECAY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; SCHOOL CHILD; SCOTOMA; SEBACEOUS NEVUS; SLEEP WALKING; STOP CODON; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

BATTEN DISEASE; CLN3; JUVENILE NEURONAL CEROID LIPOFUSCINOSIS; NEURONAL CEROID LIPOFUSCINOSIS;

CHILD; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR CHAPERONES; NEURONAL CEROID-LIPOFUSCINOSES; SEQUENCE DELETION;

EID: 84883692214 PISSN: 08830738 EISSN: 17088283 Source Type: Journal
DOI: 10.1177/0883073813494812 Document Type: Article

Times cited : (9)

References (14)

1
- 0037226939
- The neuronal ceroid-lipofuscinoses
- Haltia M. The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol. 2003 ; 62: 1-13
- (2003) J Neuropathol Exp Neurol , vol.62 , pp. 1-13
- Haltia, M.¹

2
- 84857676339
- Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses
- Kousi M, Lehesjoki AE, Mole SE. Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat. 2012 ; 33: 42-63
- (2012) Hum Mutat , vol.33 , pp. 42-63
- Kousi, M.¹ Lehesjoki, A.E.² Mole, S.E.³

3
- 84866259899
- New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses
- Williams RE, Mole SE. New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology. 2012 ; 79: 183-191
- (2012) Neurology , vol.79 , pp. 183-191
- Williams, R.E.¹ Mole, S.E.²

4
- 0023917534
- Neuronal ceroid-lipofuscinoses in childhood
- Santavuori P. Neuronal ceroid-lipofuscinoses in childhood. Brain Dev. 1988 ; 10: 80-83
- (1988) Brain Dev , vol.10 , pp. 80-83
- Santavuori, P.¹

5
- 62949195147
- Neuronal ceroid lipofuscinoses
- Jalanko A, Braulke T. Neuronal ceroid lipofuscinoses. Biochim Biophys Acta. 2009 ; 1793: 697-709
- (2009) Biochim Biophys Acta , vol.1793 , pp. 697-709
- Jalanko, A.¹ Braulke, T.²

6
- 0029147298
- Isolation of a novel gene underlying Batten disease
- Isolation of a novel gene underlying Batten disease. CLN3. Cell. 1995 ; 82: 949-957
- (1995) CLN3. Cell , vol.82 , pp. 949-957

7
- 16444366586
- CLN3, the protein associated with batten disease: Structure, function and localization
- Phillips SN, Benedict JW, Weimer JM, Pearce DA. CLN3, the protein associated with batten disease: structure, function and localization. J Neurosci Res. 2005 ; 79: 573-583
- (2005) J Neurosci Res , vol.79 , pp. 573-583
- Phillips, S.N.¹ Benedict, J.W.² Weimer, J.M.³ Pearce, D.A.⁴

8
- 1542313968
- Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells
- Kyttala A, Ihrke G, Vesa J, et al. Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells. Mol Biol Cell. 2004 ; 15: 1313-1323
- (2004) Mol Biol Cell , vol.15 , pp. 1313-1323
- Kyttala, A.¹ Ihrke, G.² Vesa, J.³

9
- 0344011621
- Characterization of Cln3p, the gene product responsible for juvenile neuronal ceroid lipofuscinosis, as a lysosomal integral membrane glycoprotein
- Ezaki J, Takeda-Ezaki M, Koike M, et al. Characterization of Cln3p, the gene product responsible for juvenile neuronal ceroid lipofuscinosis, as a lysosomal integral membrane glycoprotein. J Neurochem. 2003 ; 87: 1296-1308
- (2003) J Neurochem , vol.87 , pp. 1296-1308
- Ezaki, J.¹ Takeda-Ezaki, M.² Koike, M.³

10
- 54449095178
- Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models
- Chan CH, Mitchison HM, Pearce DA. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models. Hum Mol Genet. 2008 ; 17: 3332-3339
- (2008) Hum Mol Genet , vol.17 , pp. 3332-3339
- Chan, C.H.¹ Mitchison, H.M.² Pearce, D.A.³

11
- 84878903162
- The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis
- Miller JN, Chan CH, Pearce DA. The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis. Hum Mol Genet. 2013 ; 22: 2723-2734
- (2013) Hum Mol Genet , vol.22 , pp. 2723-2734
- Miller, J.N.¹ Chan, C.H.² Pearce, D.A.³

12
- 28744438595
- Defective lysosomal arginine transport in juvenile Batten disease
- Ramirez-Montealegre D, Pearce DA. Defective lysosomal arginine transport in juvenile Batten disease. Hum Mol Genet. 2005 ; 14: 3759-3773
- (2005) Hum Mol Genet , vol.14 , pp. 3759-3773
- Ramirez-Montealegre, D.¹ Pearce, D.A.²

13
- 3542995089
- Nonsense-mediated decay approaches the clinic
- Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE. Nonsense-mediated decay approaches the clinic. Nat Genet. 2004 ; 36: 801-808
- (2004) Nat Genet , vol.36 , pp. 801-808
- Holbrook, J.A.¹ Neu-Yilik, G.² Hentze, M.W.³ Kulozik, A.E.⁴

14
- 84867328079
- Pharmaceutical therapies to recode nonsense mutations in inherited diseases
- Lee HL, Dougherty JP. Pharmaceutical therapies to recode nonsense mutations in inherited diseases. Pharmacol Therapeutics. 2012 ; 136: 227-266
- (2012) Pharmacol Therapeutics , vol.136 , pp. 227-266
- Lee, H.L.¹ Dougherty, J.P.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.